SecBot SecBot
8-K ·Filed Sep 30, 2026

CI

Cigna Group
NEUTRAL
Impact 4/10
Horizonweeks Processed27d 20h ago SEC0001140361-26-038056
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor upcoming quarterly filings for any deviation from the 2026 guidance ranges. The $3B productivity initiative is a multi-year program with no specific margin or cost-save targets — execution details will matter more than the announcement itself.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled: T+5d
CI ▲ +2.46% at T+5d
NEUTRAL call +2.46% · α vs SPY +0.54% · entry $271.83 → $278.51
Next anchor: T+20d in 4h
Latest observation: T+17 +11.69% FF3 residual α
Entry = T+0 close
Sep 30, 2026
via day close
T+1d
-1.42%
call -1.42% · α -1.60%
$267.96
settled 27d ago
T+5d
+2.46%
call +2.46% · α +0.54%
$278.51
settled 21d ago
T+20d
Pending
in 4h
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Cigna Group held its 2026 Investor Day, reaffirming full-year 2026 guidance (adjusted EPS of at least $30.45, ~$280B adjusted revenue) and introducing a long-term 10-14% adjusted EPS CAGR target through 2030 with ~$50B in cumulative operating cash flow. The company also announced a $3B multi-year modernization and productivity initiative under its new 'Lead to One' strategic vision. This is a routine strategic update with no new financial results or surprises.

Key Facts

  • Reaffirmed 2026 adjusted EPS guidance of at least $30.45
  • Reaffirmed 2026 consolidated adjusted revenues of ~$280 billion
  • Introduced long-term target of 10-14% adjusted EPS CAGR through 2030
  • Targeting ~$50 billion in cumulative operating cash flow through 2030
  • Announced $3 billion multi-year modernization and productivity initiatives
  • Evernorth Health Services segment 2026 adjusted income from operations target of at least $6.90 billion
  • Cigna Healthcare 2026 adjusted income from operations target of at least $4.55 billion
  • Cigna Healthcare 2026 medical care ratio guidance of 83.7% to 50.7%
  • Investor Day held on September 30, 2026

Financial Impact

No financial results reported. Long-term EPS CAGR target of 10-14% and $50B cumulative operating cash flow target through 2030 announced.

revenueepscashFlow

Risk Factors

  • Execution risk on $3B modernization initiative
  • Medical care ratio within 83.7%-84.7% range could face pressure from utilization trends
  • Long-term 10-14% EPS CAGR dependent on sustained execution and market conditions

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-038056
Document: ef20082869_8k.htm0001140361-26-038056
Document: 0001140361-26-038056-index-headers.html0001140361-26-038056
Document: 0001140361-26-038056-index.html0001140361-26-038056
Document: 0001140361-26-038056.txt0001140361-26-038056
14 reports for CI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CI, sortable and filterable
TypeNow
Oct 27, 2026
today
Institutional Cluster
MIXED ★ 3/10
$304.68awaiting T+60awaiting T+60$298.28 (−2.10%)
Oct 20, 2026
7d ago
Institutional Cluster
NEUTRAL ★ 3/10
$304.37awaiting T+60awaiting T+60$298.28 (−2.00%)
Oct 9, 2026
18d ago
8-K
NEUTRAL ★ 2/10
$283.34awaiting T+60awaiting T+60$298.28 (+5.27%)
Sep 30, 2026
27d ago
8-K
NEUTRAL ★ 4/10
$271.83awaiting T+60awaiting T+60$298.28 (+9.73%)
Sep 3, 2026
7w ago
144
NEUTRAL ★ 2/10
$286.26awaiting T+60awaiting T+60$298.28 (+4.20%)
Aug 18, 2026
10w ago
144
NEUTRAL ★ 2/10
$278.50awaiting T+60awaiting T+60$298.28 (+7.10%)
Aug 4, 2026
12w ago
144
NEUTRAL ★ 2/10
$273.45awaiting T+60awaiting T+60$298.28 (+9.08%)
Jul 9, 2026
15w ago
3
NEUTRAL ★ 2/10
$293.46 $271.29▼ −7.55%▼ −10.19%$298.28 (+1.64%)
May 13, 2026
23w ago
8-K
NEUTRAL ★ 3/10
$300.42 $281.56▼ −6.28%▼ −10.45%$298.28 (−0.71%)
May 6, 2026
25w ago
Court Ruling
NEUTRAL ★ 2/10
$284.04 $274.05▼ −3.52%▼ −8.95%$298.28 (+5.01%)
Showing 10 of 14

US Market Status

Market Closed · Opens in 5h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 30, 2026